Mazumdar Claire sold BCAX
July 10, 2026 · Form 4 insider transaction
Mazumdar Claire sold 28 shares of Bicara Therapeutics Inc. at $29.68 per share, a transaction worth $831.04. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
28
Price
$29.68
Total value
$831.04
InsiderMazumdar Claire
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 10, 2026
Filing dateJuly 14, 2026
Shares owned after362,152
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2026.